CD47 and Nox1 Mediate Dynamic Fluid-Phase Macropinocytosis of Native LDL

Gábor Csányi1,2,3, Douglas M Feck1, Pushpankur Ghoshal3

  • 11 Vascular Medicine Institute, University of Pittsburgh , Pittsburgh, Pennsylvania.

Abstract

Insights

Thrombospondin-1 (TSP1) activates a novel signaling pathway in macrophages, driving macropinocytosis of native low-density lipoprotein (nLDL) and foam cell formation. This discovery sheds light on early vascular inflammation mechanisms.

Area of Science:

  • Cellular Biology
  • Molecular Signaling
  • Cardiovascular Research

Background:

  • Macropinocytosis is crucial in cardiovascular diseases, but its triggers and signaling pathways are not fully understood.
  • Physiological factors initiating fluid-phase internalization in macrophages require further identification.

Purpose of the Study:

  • To investigate if matrix protein thrombospondin-1 (TSP1) stimulates macrophage macropinocytosis.
  • To elucidate the signaling mechanisms underlying TSP1-induced macropinocytosis.

Main Methods:

  • Treatment of human and murine macrophages with TSP1.
  • Utilizing receptor blockade (CD47), enzyme inhibition (NADPH oxidase 1, phosphoinositide 3-kinase), and gene knockdown (myotubularin-related protein 6).
  • In vivo studies using peritoneal chimera in hypercholesterolemic ApoE-/- mice.

Main Results:

  • TSP1 treatment induced membrane ruffling and macropinocytosis in macrophages.
  • Inhibition of CD47, Nox1, phosphoinositide 3-kinase, and myotubularin-related protein 6 abolished TSP1-induced macropinocytosis.
  • Nox1 signaling promoted actin remodeling and uptake of native low-density lipoprotein (nLDL), leading to foam cell formation.
  • CD47 plays a role in in vivo macrophage lipid macropinocytosis.

Conclusions:

  • A novel TSP1-CD47 signaling pathway activates receptor-independent nLDL internalization, causing lipid accumulation and foam cell formation.
  • Nox1-mediated redox signaling contributes to early vascular inflammation.
  • This mechanism has broad implications for macrophages, dendritic cells, cancer cells, and diseases involving matrix protein upregulation.